| A new subset of CD103+ CD8α+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity K Fujimoto, T Karuppuchamy, N Takemura, M Shimohigoshi, T Machida, ... The Journal of Immunology 186 (11), 6287-6295, 2011 | 182 | 2011 |
| Blockade of TLR3 protects mice from lethal radiation-induced gastrointestinal syndrome N Takemura, T Kawasaki, J Kunisawa, S Sato, A Lamichhane, ... Nature communications 5 (1), 3492, 2014 | 156 | 2014 |
| Targeting cytokine signaling and lymphocyte traffic via small molecules in inflammatory bowel disease: JAK inhibitors and S1PR agonists T Pérez-Jeldres, CJ Tyler, JD Boyer, T Karuppuchamy, A Yarur, DA Giles, ... Frontiers in pharmacology 10, 212, 2019 | 111 | 2019 |
| Sphingosine-1-phosphate receptor-1 (S1P1) is expressed by lymphocytes, dendritic cells, and endothelium and modulated during inflammatory bowel disease T Karuppuchamy, EH Behrens, P González-Cabrera, G Sarkisyan, L Gima, ... Mucosal immunology 10 (1), 162-171, 2017 | 98 | 2017 |
| Characterization of diverse Acinetobacter isolates for utilization of multiple aromatic compounds K Thangaraj, A Kapley, HJ Purohit Bioresource technology 99 (7), 2488-2494, 2008 | 80 | 2008 |
| Cell trafficking interference in inflammatory bowel disease: therapeutic interventions based on basic pathogenesis concepts T Pérez-Jeldres, CJ Tyler, JD Boyer, T Karuppuchamy, G Bamias, ... Inflammatory bowel diseases 25 (2), 270-282, 2019 | 53 | 2019 |
| PRAT4A-dependent expression of cell surface TLR5 on neutrophils, classical monocytes and dendritic cells T Shibata, N Takemura, Y Motoi, Y Goto, T Karuppuchamy, K Izawa, X Li, ... International immunology 24 (10), 613-623, 2012 | 51 | 2012 |
| Bone-protective functions of netrin 1 protein K Maruyama, T Kawasaki, M Hamaguchi, M Hashimoto, M Furu, H Ito, ... Journal of Biological Chemistry 291 (46), 23854-23868, 2016 | 36 | 2016 |
| Sphingosine-1-phosphate lyase inhibition alters the S1P gradient and ameliorates Crohn’s-like ileitis by suppressing thymocyte maturation T Karuppuchamy, CJ Tyler, LR Lundborg, T Pérez-Jeldres, AK Kimball, ... Inflammatory Bowel Diseases 26 (2), 216-228, 2020 | 25 | 2020 |
| Implementation of mass cytometry as a tool for mechanism of action studies in inflammatory bowel disease CJ Tyler, T Pérez-Jeldres, E Ehinger, B Capaldo, T Karuppuchamy, ... Inflammatory bowel diseases 24 (11), 2366-2376, 2018 | 7 | 2018 |
| Targeting cytokine signaling and lymphocyte traffic via small molecules in inflammatory bowel disease: JAK inhibitors and S1PR agonists. Front Pharmacol. 2019; 10 (212): 1-15 T Pérez-Jeldres, CJ Tyler, JD Boyer, T Karuppuchamy, A Yarur, DA Giles | 6 | 2019 |
| P062 INTEGRIN ß7 DEFICIENCY RESULTS IN PAUCITY OF TERTIARY LYMPHOID TISSUES AND DECREASED LAMINA PROPRIA IGA+ B CELLS LEADING TO MICROBIOME DYSBIOSIS AND WORSE INFLAMMATION IN … JD Boyer, L Gima, T Karuppuchamy, J Rivera-Nieves Inflammatory Bowel Diseases 24 (suppl_1), S23-S24, 2018 | | 2018 |
| 971a Inflammation Modulates the Sphingosine-1-Phosphate Pathway in Inflammatory Bowel Disease (IBD) T Karuppuchamy, E Behrens, P González-Cabrera, G Sarkisyan, L Gima, ... Gastroenterology 150 (4), S195, 2016 | | 2016 |
| A New Subset of CD103+ CD8α+ Dendritic Cells in T Karuppuchamy 博士論文, 2013 | | 2013 |
| A new subset of CD103⁺ CD8α⁺ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity T Karuppuchamy 大阪大学, 2013 | | 2013 |
